{
    "ticker": "AMGN",
    "name": "Amgen Inc.",
    "description": "Amgen Inc. is one of the world\u2019s largest biotechnology companies, dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Founded in 1980, Amgen operates with the mission to serve patients by transforming the promise of science and biotechnology into therapies for those with serious illnesses. The company is known for its leading portfolio of medicines in areas such as oncology, cardiology, nephrology, and inflammation. Amgen's flagship products include Neulasta, a treatment for neutropenia, and Enbrel, which is used for autoimmune diseases. With a focus on biopharmaceuticals, Amgen emphasizes the importance of research and development, investing heavily in scientific innovation to bring new and effective treatments to market. The company is also committed to sustainability, aiming to minimize its environmental impact through energy efficiency, waste reduction, and responsible sourcing. Amgen's global presence spans over 100 countries, and it consistently ranks among the top biotech firms in the world by revenue. The company\u2019s dedication to advancing healthcare and improving patient outcomes drives its ongoing efforts in drug discovery and development.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Thousand Oaks, California, USA",
    "founded": "1980",
    "website": "https://www.amgen.com",
    "ceo": "Robert A. Bradway",
    "social_media": {
        "twitter": "https://twitter.com/amgen",
        "linkedin": "https://www.linkedin.com/company/amgen/"
    },
    "investor_relations": "https://investors.amgen.com",
    "key_executives": [
        {
            "name": "Robert A. Bradway",
            "position": "CEO"
        },
        {
            "name": "Peter Griffith",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology",
            "products": [
                "Neulasta",
                "Blincyto"
            ]
        },
        {
            "category": "Cardiology",
            "products": [
                "Repatha"
            ]
        },
        {
            "category": "Inflammation",
            "products": [
                "Enbrel"
            ]
        }
    ],
    "seo": {
        "meta_title": "Amgen Inc. | Leading Biotechnology Company",
        "meta_description": "Explore Amgen Inc., a global leader in biotechnology dedicated to developing innovative therapies for serious illnesses. Learn about our commitment to science and patient care.",
        "keywords": [
            "Amgen",
            "Biotechnology",
            "Pharmaceuticals",
            "Healthcare",
            "Oncology",
            "Enbrel",
            "Neulasta"
        ]
    },
    "faq": [
        {
            "question": "What does Amgen specialize in?",
            "answer": "Amgen specializes in biotechnology and pharmaceuticals, focusing on innovative therapies for serious illnesses."
        },
        {
            "question": "Who is the CEO of Amgen?",
            "answer": "Robert A. Bradway is the CEO of Amgen Inc."
        },
        {
            "question": "Where is Amgen headquartered?",
            "answer": "Amgen is headquartered in Thousand Oaks, California, USA."
        },
        {
            "question": "What are some of Amgen's key products?",
            "answer": "Key products include Neulasta, Enbrel, and Repatha."
        },
        {
            "question": "When was Amgen founded?",
            "answer": "Amgen was founded in 1980."
        }
    ],
    "competitors": [
        "REGN",
        "VRTX",
        "GILD",
        "BIIB"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "ABBV"
    ]
}